Cynata OTC Stock Technical Analysis

CYYNF -  USA Stock  

USD 0.40  0.00  0.00%

As of the 30th of November, Cynata Therapeutics shows the mean deviation of 0.5944, and Risk Adjusted Performance of 0.1392. Cynata Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate nineteen technical drivers for Cynata Therapeutics, which can be compared to its rivals. Please confirm Cynata Therapeutics coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and semi variance to decide if Cynata Therapeutics is priced correctly, providing market reflects its regular price of 0.4 per share. As Cynata Therapeutics is a penny stock we also strongly suggest to validate its total risk alpha numbers.

Cynata Technical Analysis 

 
Refresh
Cynata Therapeutics technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Cynata Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Cynata Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Cynata Therapeutics Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Cynata Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility. View also all equity analysis or get more info about average true range volatility indicators indicator.

Cynata Therapeutics Trend Analysis

Use this graph to draw trend lines for Cynata Therapeutics. You can use it to identify possible trend reversals for Cynata Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Cynata Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Cynata Therapeutics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Cynata Therapeutics applied against its price change over selected period. The best fit line has a slop of   0.0014  , which means Cynata Therapeutics will continue generating value for investors. It has 122 observation points and a regression sum of squares at 0.07, which is the sum of squared deviations for the predicted Cynata Therapeutics price change compared to its average price change.

About Cynata Therapeutics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Cynata Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Cynata Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Cynata Therapeutics stock first instead of the macroeconomic environment surrounding Cynata Therapeutics. By analyzing Cynata Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Cynata Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Cynata Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.

Cynata Therapeutics November 30, 2021 Technical Indicators

Most technical analysis of Cynata help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Cynata from various momentum indicators to cycle indicators. When you analyze Cynata charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Continue to Trending Equities. Note that the Cynata Therapeutics information on this page should be used as a complementary analysis to other Cynata Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try CEO Directory module to screen CEOs from public companies around the world.

Complementary Tools for Cynata OTC Stock analysis

When running Cynata Therapeutics price analysis, check to measure Cynata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cynata Therapeutics is operating at the current time. Most of Cynata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cynata Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cynata Therapeutics' price. Additionally, you may evaluate how the addition of Cynata Therapeutics to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Is Cynata Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cynata Therapeutics. If investors know Cynata will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cynata Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Cynata Therapeutics is measured differently than its book value, which is the value of Cynata that is recorded on the company's balance sheet. Investors also form their own opinion of Cynata Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Cynata Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cynata Therapeutics' market value can be influenced by many factors that don't directly affect Cynata Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cynata Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Cynata Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cynata Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.